Safety and Efficacy Evaluation of IM83 CAR-T Cells for Patients With Advanced Liver Tumors
Clinical trial NCT05123209 · UNKNOWN
Trial details
- NCT number
- NCT05123209
- Sponsor
- Beijing Immunochina Medical Science & Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-24
- Primary completion
- 2023-08-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.